MedPath

â?? A clinical trial to study the effects of Virechana Karma, and Haridradi Avleha in the patient having symptomts of Tamaka Shwasa w.s.r to Bronchial Asthma. â??

Phase 2
Completed
Conditions
Health Condition 1: null- Patients having symptoms of tamaka shwasa (Bronchial Asthma)
Registration Number
CTRI/2017/12/010920
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Patients willing for trial and give consent.

2.Patients of age group 18 to 60 years of either sex.

3.Patients having signs and symptoms of Tamaka Shwasa (Bronchial asthma) as mentioned in Ayurvedic and Modern texts.

4.Patients fit for Virechana Karma.

Exclusion Criteria

1.Patients not willing for trial.

2.Age below 18 and above 60years of either sex.

3.Patients suffering from Pulmonary Tuberculosis, Anaemia, Bronchus/Bronchogenic carcinoma, Chronic obstructive pulmonary disease, Pleural effusion.

4.Status asthmaticus.

5.Patients with rectal or vaginal prolapse.

6.Pregnant and lactating women.

7.Pateints suffering from serious systemic disorders like renal diseases, heart diseases, malignant hypertention, Diabetes Mellitus.Patients who are unfit for Virechana Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients of both sexes between age group 18-60 of tamak shwasa will be selected for relieving signs and symptomsTimepoint: Patients of both sexes between age group 18-60 of tamak shwasa will be selected for relieving signs and symptoms
Secondary Outcome Measures
NameTimeMethod
Assess the comparative efficacy between Haridradi Avleha and Virechana Karma after 4 weeks in case of Tamaka ShwasaTimepoint: Assess the comparative efficacy between Haridradi Avleha and Virechana Karma after 4 weeks in case of Tamaka Shwasa
© Copyright 2025. All Rights Reserved by MedPath